Skip to main content

Table 3 Treatment delivery, n = 18

From: A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma

  n (%)
Number of cycles
≤ 4 2 (11 %)
5-8 8 (44 %)
9-12 7 (39 %)
≥ 13 1 (6 %)
Median 8 cycles
Dose intensity*
Total number of cycles 146
Number of cycles at full dose 121 (83 %)
Number of cycles at reduced dose 25 (17 %)
Number of cycles delayed by ≥ 1 week 13 (9 %)
5-Fluorouracil dose intensity 98 %
Irinotecan dose intensity 95 %
Oxaliplatin dose intensity 98 %
  1. *Dose intensity is defined as the dose delivered divided by the full dose.